Oxford Asset Management’s Novavax NVAX Stock Holding History

Oxford Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$150K	Sell	15,921 -3,862	-20%	-$34.6K	0.07%	331
2026 Q1	$161K	Sell	19,783 -1,728	-8%	-$15.7K	0.07%	396
2025 Q4	$145K	Buy	+21,511	New	+$162K	0.05%	423
2018 Q3	–	Sell	-26,181	Closed	-$699K	–	1861
2018 Q2	$699K	Buy	26,181 +21,274	+434%	+$719K	0.01%	1214
2018 Q1	$206K	Sell	4,907 -5,353	-52%	-$215K	﹤0.01%	1483
2017 Q4	$267K	Buy	+10,260	New	+$250K	0.01%	1367
2017 Q1	–	Sell	-4,236	Closed	-$107K	–	1450
2016 Q4	$107K	Sell	4,236 -29,189	-87%	-$851K	﹤0.01%	731
2016 Q3	$1.39M	Buy	+33,425	New	+$4.32M	0.04%	465
2016 Q1	–	Sell	-4,874	Closed	-$812K	–	861
2015 Q4	$812K	Sell	4,874 -3,751	-43%	-$577K	0.02%	583
2015 Q3	$1.22M	Buy	+8,625	New	+$1.93M	0.04%	372

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Oxford Asset Management's NVAX Position: Q2 2026 in Review

Oxford Asset Management reduced its Novavax (NVAX) stake by 20% in Q2 2026, selling an estimated $34.6K and leaving 15,921 shares worth $150K. The position accounts for 0.07% of the portfolio, ranked #331.

Oxford Asset Management first reported a position in NVAX in Q3 2015 and has held it in 10 quarters since. The position peaked at $1.39M in Q3 2016. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Oxford Asset Management held 15,921 shares of Novavax worth $150K as of Q2 2026.
Oxford Asset Management sold 3,862 Novavax shares in Q2 2026, an estimated $34.6K.
Novavax made up 0.07% of Oxford Asset Management's portfolio in Q2 2026, its #331 holding.
Oxford Asset Management first reported a position in Novavax in Q3 2015 and has held it in 10 quarters since.
Oxford Asset Management's Novavax position peaked at $1.39M in Q3 2016.
267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.